NEW YORK, Jan. 21, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ: TMDX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
